About Matrix Pharmacorp Private Limited
Data last updated:
Matrix Pharmacorp Private Limited is a private limited company based in Sangareddy, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 October 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33110TG2022PTC167288. Its GSTIN is 36AAQCM2569M1ZO (Telangana).
The company has an authorised share capital of ₹3,001.2 Cr and a paid-up capital of ₹1,185.36 Cr. It is led by directors including Ashven Datla and Pranav Gunupati Venkata Reddy.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sangareddy, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹4,422.21 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹278.62 Cr (net margin 6.3%) and EBITDA of ₹936.99 Cr (EBITDA margin 21.2%).
As per MCA filings, the company has open charges of ₹8,000 Cr on record. Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 2 cases are pending. The company has 4 deals on record (2 funding rounds, 1 rights issue, 1 debt financing), with disclosed funding of ₹2,261.35 Cr; the latest was in July 2024. Its 8 peer companies in the Healthcare industry (API Manufacturers, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Usv Private Limited with revenue of ₹5,202.13 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website matrixpharma.co.in.
Company details
Contact details
Matrix Pharmacorp Private Limited's registered office is in Sangareddy, Telangana. Its website is matrixpharma.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 14 99 And 100 Ida, Pashamylaram Phase II Patancheru, Sangareddy, Telangana, India – 502307
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Matrix Pharmacorp Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Matrix Pharmacorp is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Matrix Pharmacorp Private Limited
FY 2025 filings availableMatrix Pharmacorp Private Limited reported revenue of ₹4,422.21 Cr (up 16378466% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹936.99 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹278.62 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 21.2% | ||
| Net Profit Margin | 6.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Matrix Pharmacorp Private Limited, buy the company report.
Board of directors of Matrix Pharmacorp Private Limited
Matrix Pharmacorp has 4 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashven Datla Also directs: Ashven Resources LLP, Procural Private Limited, Modular Containers Private Limited and 3 more | Director | 29 Sep 2025 | 1 Years 0 Months | Current |
| Pranav Gunupati Venkata Reddy | Director | 14 Aug 2023 | 3 Years 2 Months | Current |
| Swathi Reddy Gunupati Also directs: Mudhra Ventures LLP, Mudhra Labs Private Limited, Monochrome Foods Private Limited and 5 more | Director | 14 Aug 2023 | 3 Years 2 Months | Current |
| Govinda Prasad Dasu Also directs: Moschip Technologies Limited | Director | 08 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Matrix Pharmacorp Private Limited is compared with the 8 companies closest to it by revenue in the Healthcare industry (API Manufacturers, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Usv Private Limited | ₹5,202.13 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Natco Pharma Limited | ₹4,784 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Granules India Limited | ₹4,494.53 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Matrix Pharmacorp Private Limitedthis company | ₹4,422.21 Cr (FY 2025) | ₹278.62 Cr | 6.3% | 16378466.0% | Sangareddy, Telangana, India | |
| Cadila Pharmaceuticals Limited | ₹3,869.17 Cr (FY 2025) | 4.0% | Ahmedabad, Gujarat, India | |||
| Hetero Drugs Limited | ₹3,323.92 Cr (FY 2025) | 13.0% | Hyderabad, Telangana, India | |||
| Dishman Carbogen Amcis Limited | ₹2,733.18 Cr (FY 2025) | 3.0% | Ahmedabad, Gujarat, India | |||
| Covalent Laboratories Private Limited | ₹2,693.24 Cr (FY 2025) | -8.0% | Hyderabad, Telangana, India | |||
| Honour Lab Limited | ₹2,482.63 Cr (FY 2025) | 4.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Matrix Pharmacorp Private Limited, buy the company report.
Auditor
Matrix Pharmacorp Private Limited is audited by C. Maruti Nagendram for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C. Maruti Nagendram | FY 2023 | 203897 |
Shareholding
The shareholding of Matrix Pharmacorp Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Matrix Pharmacorp Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jul 2024 | 100968645 | Others | ₹1,500 Cr | Open | |
| 24 Jul 2024 | 100949946 | Others | ₹1,500 Cr | Open | |
| 29 Jun 2024 | 100940263 | Others | ₹2,500 Cr | Open | |
| 12 May 2024 | 100921622 | Others | ₹2,500 Cr | Open |
To see the full charge records of Matrix Pharmacorp Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Matrix Pharmacorp Private Limited has 4 deals on record (2 funding rounds, 1 rights issue, 1 debt financing), with disclosed funding of ₹2,261.35 Cr; the latest was in July 2024.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2024 | Funding round | ₹1,445 Cr | Investors: Kotak Special Situations Fund |
| May 2024 | Debt financing | ₹815 Cr | Investors: Kotak Special Situations Fund, Nuvama Wealth and Investment Limited , Sanguinity Trading Company Private Limited |
| Apr 2024 | Rights issue | ₹1,184 Cr | Investors: Mudhra Labs Private Limited |
| Sep 2023 | Funding round | ₹1.35 Cr | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Matrix Pharmacorp Private Limited has 8 court cases on record: 2 filed by Matrix Pharmacorp, 6 filed against it. 2 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLAT | 4 | 4 | 0 |
| High courts | 2 | 0 | 2 |
| Supreme Court | 2 | 2 | 0 |
Cases on record (3 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Appeal | Filed by the company against Iquest Enterprises Private Limited and 4 others | Pending |
| NCLAT, NCLAT Chennai | Interim or miscellaneous application | Filed against the company by Ras AI Khaima Investment Authority | Disposed |
| Supreme Court | Appeal | Filed against the company by Ras Al Khaimah Investment Authority | Disposed |
To see the full case history of Matrix Pharmacorp Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Matrix Pharmacorp Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Matrix Pharmacorp Private Limited has 1 active EPFO establishment as of Dec 15, 2024.
GST
Matrix Pharmacorp has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAQCM2569M1ZO | Telangana | Active | 10 Aug 2023 |
To see the full GST registrations and return filing status of Matrix Pharmacorp Private Limited, buy the company report.
Recent activity
Matrix Pharmacorp Private Limited has 10 board changes on record since 2023: 4 appointments and 6 cessations. The latest: Ashven Datla was appointed as Director on 29 Sep 2025.
9 earlier events are in the company report.
Frequently asked questions
Matrix Pharmacorp is an active private limited company based in Sangareddy, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 October 2022 (4+ years old) and is registered under CIN U33110TG2022PTC167288.
Matrix Pharmacorp has 4 current directors:
- Ashven Datla - Director
- Pranav Gunupati Venkata Reddy - Director
- Swathi Reddy Gunupati - Director
- Govinda Prasad Dasu - Director
The latest financial statements of Matrix Pharmacorp on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Matrix Pharmacorp is 36AAQCM2569M1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Matrix Pharmacorp is U33110TG2022PTC167288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Matrix Pharmacorp has 8 court cases on record: 2 filed by the company and 6 filed against it. 2 are pending. Most are in the nclat.
Matrix Pharmacorp was incorporated on 07 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Matrix Pharmacorp has 4 deals on record (2 funding rounds, 1 rights issue, 1 debt financing), with disclosed funding of ₹2,261.35 Cr; the latest was in July 2024.
The peers of Matrix Pharmacorp by revenue are Usv Private Limited, Natco Pharma Limited, Granules India Limited, Cadila Pharmaceuticals Limited, Hetero Drugs Limited and 3 more, all in the Healthcare industry (API Manufacturers, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashven Datla was appointed as Director on 29 Sep 2025. Anil Kumar Jain ceased to be Additional Director on 30 Sep 2024. Govinda Prasad Dasu was appointed as Director on 08 Apr 2024. Matrix Pharmacorp has 10 board changes on record in total.
Matrix Pharmacorp can be reached through the website matrixpharma.co.in. Its registered office is in Sangareddy, Telangana, India.